President Donald Trump says his administration is weighing a plan that would reschedule marijuana from a Schedule I drug to Schedule III. It's a shift that would formally recognize cannabis as having accepted medical use under federal law for the first time. On Monday, the president answered a question about the proposal to reclassify marijuana as a less dangerous drug during an event at the White House. Mr.
Main Idea: President Donald Trump is weighing a plan to move marijuana to Schedule III, a change that could ease taxes and research rules but would not fully legalize cannabis.
Key Points:
Schedule III could bring new federal rules and higher compliance costs, which may hurt small cannabis businesses and keep legal confusion for workers and customers.
Rescheduling could cut tax burdens, expand research, and make medical cannabis more available for patients and some taxpayers.
Rate how each entity in this article affected the American people.
Central actor whose stated move to reschedule marijuana drives the article.
Named executive quoted on the shift toward pharma-grade standards.
Named company tied to Alex Gonzalez’s quoted comments.
Named CEO quoted on operational and legal concerns under Schedule III.
Named company tied to Joe Gerrity’s quoted concerns.
Named company associated with Harrison Bard and his comments.
Named CEO quoted on the effects for small operators.
Named cannabis company whose founder warns about federal compliance risks.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentNamed publisher whose founder is quoted warning about the proposal.
Named cannabis retailer quoted on legal incentives and compliance.
Named CEO quoted on hemp THC restrictions and regulatory confusion.
Named industry figure and publisher quoted as a critic of rescheduling.